EGFR exhibits increased expression in various solid tumors, including non-small cell lung cancer, breast cancer, ovarian cancer, as well as head and neck squamous cell carcinoma.166,167 EGFR mAb-decorated nanoparticles showed superior tumor-targeting capacity and enhanced antitumor efficacy in preclinical models and clinical trials. Here, EGFR is linked to ovarian cancer.